Active Pharmaceutical Ingredient (API)
Sofosbuvir
Antiviral (Hepatitis C - $\text{NS5B}$ Inhibitor)
A nucleotide analog inhibitor of the $\text{NS5B}$ polymerase, a viral enzyme critical for Hepatitis C Virus ($\text{HCV}$) replication. It is a cornerstone of modern, highly effective, all-oral $\text{HCV}$ treatment regimens (Direct-Acting Antivirals), leading to high cure rates globally.
Technical Profile
- Reference Code
- SOF301
- CAS Number
- 1190307-88-0
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Sofosbuvir as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Hepcvel H | Cipla Limited | Tablet (400 mg) | ₹16,406.25 | View Details |
| Hepcvir 400 H | Cipla Limited | Tablet (400 mg) | ₹9,500.00 | View Details |
| Ledifos H | Cipla Limited | Tablet (400 mg) | ₹15,000.00 | View Details |
| Hepcinat 400 H | Natco Pharma Ltd | Tablet (400 mg) | ₹14,062.50 | View Details |
| Hepcinat LP H | Natco Pharma Ltd | Tablet (400 mg) | ₹18,500.00 | View Details |
| Velpafresh H | Laurus Labs Limited | Tablet (400 mg) | ₹16,500.00 | View Details |